Longitude Capital Partners IV, LLC - Significant Ownership

Signature - Title
/s/ Cristiana Blauth Oliveira - Cristiana Blauth Oliveira, Authorized Signatory
Location
Menlo Park, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Longitude Capital Partners IV, LLC.

Significant Ownership of Longitude Capital Partners IV, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CGON CG Oncology, Inc. Common Stock, $0.0001 par value per share 6% $121M 4.66M Patrick G. Enright Sep 11, 2025
ZBIO ZENAS BIOPHARMA, INC. Common Stock, $0.0001 par value per share 4.9% $58.4M 2.63M Patrick G. Enright Oct 9, 2025
LXEO Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) 3.8% $18.4M 2.77M Longitude Capital Partners IV, LLC Sep 30, 2025

Schedules 13D/G Reported by Longitude Capital Partners IV, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.